Rare diseases
Investigational molecules
Locations
Nordre Fasanvej 215, 2000 Frederiksberg, Denmark
The sponsor concentrates on developing therapeutic interventions for cardiac rhythm disorders, with particular emphasis on atrial fibrillation treatment. Research efforts are directed toward pharmacological solutions that address abnormal heart rhythm patterns and restore normal cardiac electrical activity.
The clinical development program focuses on novel approaches to managing supraventricular arrhythmias, seeking to provide effective pharmacological options for patients experiencing irregular heartbeat conditions. This work addresses a significant unmet medical need in cardiovascular medicine.
Acesion Pharma ApS runs clinical trials in conditions such as Atrial fibrillation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
